---
schema_version: "secwatch.filing_event.v1"
accession: "0001023024-25-000113"
form_type: "8-K"
ticker: "ANIP"
cik: "0001023024"
company_name: "ANI PHARMACEUTICALS INC"
filed_at: "2025-12-01T23:59:59+00:00"
generated_at: "2026-05-16T15:49:42.558786+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# ANI Pharmaceuticals names Thomas J. Haughey as new Chairman; Patrick Walsh to retire at 2026 annual meeting

## Summary
- Patrick D. Walsh will not seek re-election as director and steps down as Chairman; no disagreement with board or management.
- Thomas J. Haughey elected Chairman; he has served on the board since May 2018.
- Jeanne A. Thoma replaces Haughey as Chair of Audit and Finance Committee; Haughey remains on the committee.
- Walsh's retirement effective after the 2026 Annual Meeting of Stockholders.

## SEC filing metadata
- accession: 0001023024-25-000113
- form_type: 8-K
- ticker: ANIP
- cik: 0001023024
- company_name: ANI PHARMACEUTICALS INC
- filed_at: 2025-12-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000113/0001023024-25-000113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1023024/000102302425000113/ani-20251124.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001023024-25-000113
- JSON: https://secwatch.observer/filing/0001023024-25-000113.json
- Plain text: https://secwatch.observer/filing/0001023024-25-000113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.